ES2229510T3 - Derivados de anillo aromatico. - Google Patents
Derivados de anillo aromatico.Info
- Publication number
- ES2229510T3 ES2229510T3 ES98929724T ES98929724T ES2229510T3 ES 2229510 T3 ES2229510 T3 ES 2229510T3 ES 98929724 T ES98929724 T ES 98929724T ES 98929724 T ES98929724 T ES 98929724T ES 2229510 T3 ES2229510 T3 ES 2229510T3
- Authority
- ES
- Spain
- Prior art keywords
- group
- alkyl
- aromatic
- formula
- heterocyclic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
- C07C311/51—Y being a hydrogen or a carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/68—Halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP18784997 | 1997-06-27 | ||
| JP18784997 | 1997-06-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2229510T3 true ES2229510T3 (es) | 2005-04-16 |
Family
ID=16213302
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES98929724T Expired - Lifetime ES2229510T3 (es) | 1997-06-27 | 1998-06-26 | Derivados de anillo aromatico. |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US6242474B1 (fr) |
| EP (1) | EP1000932B9 (fr) |
| DE (1) | DE69826286T2 (fr) |
| ES (1) | ES2229510T3 (fr) |
| WO (1) | WO1999000359A1 (fr) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU745081B2 (en) * | 1997-06-27 | 2002-03-14 | Fujisawa Pharmaceutical Co., Ltd. | Sulfonamide compounds and medicinal use thereof |
| KR20010052235A (ko) * | 1998-04-06 | 2001-06-25 | 후지야마 아키라 | 인돌 유도체 |
| HK1044154A1 (zh) | 1998-12-04 | 2002-10-11 | 藤泽药品工业株式会社 | 磺酰胺化合物及其药物用途 |
| ES2292262T3 (es) * | 1998-12-24 | 2008-03-01 | Astellas Pharma Inc. | Compuestos de imidazol y su uso medicinal. |
| US6821978B2 (en) | 2000-09-19 | 2004-11-23 | Schering Corporation | Xanthine phosphodiesterase V inhibitors |
| US20020046127A1 (en) * | 2000-10-18 | 2002-04-18 | Gary Reding | System and method for automated commodities transactions including an automatic hedging function |
| SE0102299D0 (sv) | 2001-06-26 | 2001-06-26 | Astrazeneca Ab | Compounds |
| SE0102764D0 (sv) * | 2001-08-17 | 2001-08-17 | Astrazeneca Ab | Compounds |
| CA2465893A1 (fr) | 2001-11-09 | 2003-05-22 | Schering Corporation | Inhibiteurs de la phosphodiesterase v de derives polycycliques de guanine |
| JP2005519927A (ja) * | 2002-02-07 | 2005-07-07 | ファイザー・インク | 多嚢胞性卵巣症候群の処置における、シルデナフィル如きｐｄｅ５インヒビターの使用 |
| GB0226930D0 (en) | 2002-11-19 | 2002-12-24 | Astrazeneca Ab | Chemical compounds |
| GB0309154D0 (en) | 2003-01-14 | 2003-05-28 | Aventis Pharma Inc | Use of insulin glargine to reduce or prevent cardiovascular events in patients being treated for dysglycemia |
| KR20070007104A (ko) * | 2004-02-18 | 2007-01-12 | 아스트라제네카 아베 | 화합물 |
| BRPI0507746A (pt) * | 2004-02-18 | 2007-07-10 | Astrazeneca Ab | composto ou um sal, pró-droga ou solvato do mesmo, composição farmacêutica, método de tratar doenças mediadas por glk, e, processo para a preparação de um composto |
| US20050197376A1 (en) * | 2004-03-02 | 2005-09-08 | Fujisawa Pharmaceutical Co. Ltd. | Concomitant drugs |
| TW200600086A (en) * | 2004-06-05 | 2006-01-01 | Astrazeneca Ab | Chemical compound |
| GB0423043D0 (en) * | 2004-10-16 | 2004-11-17 | Astrazeneca Ab | Compounds |
| KR20070085371A (ko) * | 2004-10-16 | 2007-08-27 | 아스트라제네카 아베 | 페녹시 벤즈아미드 화합물의 제조 방법 |
| EP1891069A1 (fr) * | 2005-05-24 | 2008-02-27 | AstraZeneca AB | Derives d'imidazol[4,5b]pyridine/pyrazine et purine substitues en 2-phenyl en tant que modulateurs de la glucokinase |
| TW200714597A (en) * | 2005-05-27 | 2007-04-16 | Astrazeneca Ab | Chemical compounds |
| JP2009500442A (ja) * | 2005-07-09 | 2009-01-08 | アストラゼネカ アクチボラグ | ２型糖尿病を処置するためのグルコキナーゼのモジュレーターとしての２−ヘテロシクリルオキシベンゾイルアミノヘテロシクリル化合物 |
| KR101346902B1 (ko) * | 2005-07-09 | 2014-01-02 | 아스트라제네카 아베 | 당뇨병 치료에 있어 ｇｌｋ 활성화제로서 사용하기 위한헤테로아릴 벤즈아미드 유도체 |
| EP2027113A1 (fr) * | 2005-07-09 | 2009-02-25 | AstraZeneca AB | Dérivés d'hétéroaryl benzamide utilisés en tant qu'activateurs de la glk dans le traitement du diabète |
| TW200740435A (en) * | 2005-08-10 | 2007-11-01 | Takeda Pharmaceuticals Co | Therapeutic agent for diabetes |
| US9202182B2 (en) * | 2005-08-11 | 2015-12-01 | International Business Machines Corporation | Method and system for analyzing business architecture |
| TW200738621A (en) * | 2005-11-28 | 2007-10-16 | Astrazeneca Ab | Chemical process |
| TW200806641A (en) * | 2006-01-25 | 2008-02-01 | Synta Pharmaceuticals Corp | Substituted aromatic compounds for inflammation and immune-related uses |
| TW200825063A (en) * | 2006-10-23 | 2008-06-16 | Astrazeneca Ab | Chemical compounds |
| TW200825060A (en) * | 2006-10-26 | 2008-06-16 | Astrazeneca Ab | Chemical compounds |
| KR20090090390A (ko) * | 2006-12-21 | 2009-08-25 | 아스트라제네카 아베 | Ｇｌｋ 활성제로서 유용한 신규 결정 화합물 |
| EP2324028A2 (fr) * | 2008-08-04 | 2011-05-25 | AstraZeneca AB | Agents thérapeutiques 414 |
| GB0902434D0 (en) * | 2009-02-13 | 2009-04-01 | Astrazeneca Ab | Chemical process |
| GB0902406D0 (en) * | 2009-02-13 | 2009-04-01 | Astrazeneca Ab | Crystalline polymorphic form |
| AR076221A1 (es) * | 2009-04-09 | 2011-05-26 | Astrazeneca Ab | Derivado de pirazol [4,5-e] pirimidina y su uso para tratar diabetes y obesidad |
| WO2010116177A1 (fr) | 2009-04-09 | 2010-10-14 | Astrazeneca Ab | Dérivé de pyrazolo [4,5-e] pyrimidine et son utilisation pour traiter le diabète et l'obésité |
| KR20180088412A (ko) | 2015-12-11 | 2018-08-03 | 데이진 화-마 가부시키가이샤 | 아미노아졸 유도체 |
| US11263707B2 (en) | 2017-08-08 | 2022-03-01 | Indigo Ag, Inc. | Machine learning in agricultural planting, growing, and harvesting contexts |
| WO2019209947A1 (fr) | 2018-04-24 | 2019-10-31 | Indigo Ag, Inc. | Gestion d'interaction dans un système agricole en ligne |
| US11367093B2 (en) | 2018-04-24 | 2022-06-21 | Indigo Ag, Inc. | Satellite-based agricultural modeling |
| GB201905721D0 (en) | 2019-04-24 | 2019-06-05 | Univ Dundee | Compounds |
| WO2023034118A1 (fr) | 2021-08-30 | 2023-03-09 | Indigo Ag, Inc. | Systèmes de gestion de données de marché tenant compte de l'emplacement |
| CA3230474A1 (fr) | 2021-08-31 | 2023-03-09 | Eleanor Elizabeth Campbell | Systemes et procedes pour des recommandations de credit ecosysteme |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2457371A (en) * | 1943-11-05 | 1948-12-28 | Geigy Ag J R | Acylated p-aminobenzene sulfonamides |
| DE1182243B (de) * | 1963-01-04 | 1964-11-26 | Basf Ag | Verfahren zur Herstellung von Aminoaroyl-sulfonylimiden |
| US5298502A (en) * | 1988-12-12 | 1994-03-29 | Fmc Corporation | Method and composition for photodynamic treatment and detection of tumors |
| US5157040A (en) * | 1991-04-05 | 1992-10-20 | Merck & Co., Inc. | Substituted quinolines as angiotensin ii antagonists |
| WO1994026273A1 (fr) * | 1993-05-12 | 1994-11-24 | Hostetler Karl Y | Derives d'acyclovir a usage topique |
| GB9514160D0 (en) | 1994-07-25 | 1995-09-13 | Zeneca Ltd | Aromatic compounds |
| JP3117721B2 (ja) | 1994-11-24 | 2000-12-18 | エフ・ホフマン−ラ ロシュ アーゲー | 新規なベンジルピリミジン類 |
| TW502026B (en) | 1995-06-20 | 2002-09-11 | Zeneca Ltd | Aromatic compounds useful as antagonists of e-type prostaglandins, processes for the preparation thereof, pharmaceutical compositions comprising the compounds, and intermediates |
| TW434240B (en) | 1995-06-20 | 2001-05-16 | Zeneca Ltd | Aromatic compounds, preparation thereof and pharmaceutical composition comprising same |
| WO1997022586A1 (fr) | 1995-12-15 | 1997-06-26 | Merck Frosst Canada Inc. | Derives d'ethane tri-aryle utilises comme inhibiteurs de pde iv |
| WO1997024334A1 (fr) | 1995-12-28 | 1997-07-10 | Fujisawa Pharmaceutical Co., Ltd. | Derives du benzimidazole |
| US5824657A (en) * | 1997-03-18 | 1998-10-20 | Cubist Pharmaceuticals, Inc. | Aminoacyl sulfamides for the treatment of hyperproliferative disorders |
-
1998
- 1998-06-26 EP EP98929724A patent/EP1000932B9/fr not_active Expired - Lifetime
- 1998-06-26 DE DE69826286T patent/DE69826286T2/de not_active Expired - Fee Related
- 1998-06-26 US US09/446,619 patent/US6242474B1/en not_active Expired - Fee Related
- 1998-06-26 ES ES98929724T patent/ES2229510T3/es not_active Expired - Lifetime
- 1998-06-26 WO PCT/JP1998/002886 patent/WO1999000359A1/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999000359A1 (fr) | 1999-01-07 |
| DE69826286T2 (de) | 2005-11-24 |
| EP1000932B1 (fr) | 2004-09-15 |
| DE69826286D1 (de) | 2004-10-21 |
| US6242474B1 (en) | 2001-06-05 |
| EP1000932A4 (fr) | 2000-08-09 |
| EP1000932B9 (fr) | 2005-12-28 |
| EP1000932A1 (fr) | 2000-05-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2229510T3 (es) | Derivados de anillo aromatico. | |
| ES2244979T3 (es) | Derivados de benzimidazol. | |
| KR100832934B1 (ko) | 치환된 2-티오-3,5-디시아노-4-아릴-6-아미노피리딘 및 그의 용도 | |
| ES2329670T3 (es) | Derivados de piridazina. | |
| ES2339646T3 (es) | Ariloximas. | |
| KR0171409B1 (ko) | 아실 화합물 및 이를 함유하는 약제학적 화합물 | |
| KR100394761B1 (ko) | 헤테로바이사이클릭유도체 | |
| US6346532B1 (en) | Amide derivatives or salts thereof | |
| TWI426908B (zh) | 特定化學品、組成物及方法 | |
| US6420409B1 (en) | Benzimidazole derivatives | |
| KR20050122210A (ko) | 히스톤 탈아세틸화 효소 억제제 | |
| CA2870666A1 (fr) | Compositions et methodes pour moduler l'activite 15-pgdh | |
| ES2322964T3 (es) | Amidas sustituidas con heteroarilo que comprenden un grupo de union insaturado o ciclico, y su uso como agentes farmaceuticos. | |
| DE4432860A1 (de) | Imidazopyridine | |
| BR112020019560A2 (pt) | Moduladores de calpaína e usos terapêuticos dos mesmos | |
| ES2292462T3 (es) | Agentes abridores de los canales del potasio. | |
| PT77855B (en) | Pyridine derivatives | |
| HU199418B (en) | Process for producing new, substituted anilide derivatives | |
| CZ20011981A3 (cs) | Sulfonamidové sloučeniny | |
| CA2241186C (fr) | Derives du benzimidazole | |
| EP1132087A1 (fr) | Remedes contre le syndrome des ovaires polykystiques | |
| JP2001525398A (ja) | 選択的β３アドレナリン作動性アゴニスト | |
| KR100516080B1 (ko) | 벤즈이미다졸유도체 | |
| JPWO1999000359A1 (ja) | 芳香環誘導体 | |
| GB2038798A (en) | (Hydroxymethyl imidazolyl) methylthioethyl guanidine derivatives |